| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 790,909,047 | 833,728,170 | -5.135 | 791,827,797 | -0.116 |
| Gross Profit (Loss) | 385,259,335 | 372,598,003 | 3.398 | 368,859,731 | 4.446 |
| Operational Profit (Loss) | 192,085,715 | 189,301,115 | 1.47 | 119,688,569 | 60.487 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 173,138,809 | 171,871,096 | 0.737 | 152,574,252 | 13.478 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 172,515,689 | 176,723,126 | -2.38 | 156,953,969 | 9.914 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 3,134,506,371 | 2,700,529,204 | 16.07 |
| Profit (Loss) per Share | 2.16 | 2.15 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenue decreases in general due to: |
Decrease in revenue in the following segments:
a) Steel Industry
b) Specialty chemical.
While noting that there is slight increase in revenue in pharmaceuticals segment.
1. Increase in Gross Profit in the following segments:
a) Pharmaceuticals
b) Steel Industry
2. Decrease in finance costs mainly in the following segments:
a) Specialty Chemical
b) Pharmaceuticals.
While noting that there is decrease in other income, net in other segment.
Decrease in sales in steel segment.
While noting that there is increase in sales in the pharmaceuticals segment.
1. Increase Gross Profit in Profit in the following segments:
a. Pharmaceuticals
b. Specialty chemical
While noting that there is decrease in Gross Profit in Steel industries.
2. Decrease in General and administrative expenses in following sectors:
a) Steel industries
b) Specialty chemical
3. Decrease in Provision for impairment of financial assets expenses in following sectors:
a) Steel industries
b) Specialty chemical
While noting that there is decrease in share in profit from unconsolidated subsidiary.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.